Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

This Italian startup is working hard to develop the first vaccine to kill coronavirus: Will it win the race?

Shubham Sharma by Shubham Sharma
May 14, 2020
in News, COVID-19, Health & Medtech, Startups
0
This Italian startup is working hard to develop the first vaccine to kill coronavirus: Will it win the race?
143
SHARES
LinkedInTwitterWhatsAppFacebook

The entire world is racing to develop a vaccine for the novel coronavirus. Multiple pharmaceutical companies, startups, and test labs are working around the globe to come up with a vaccine. One such company is a humble startup from Europe called Takis Biotech. The Italian startup has been working on a vaccine for COVID-19 and has now announced a new milestone in its journey. 

Takis Biotech produces coronavirus neutralising antibodies in test animals

Takis Biotech pivoted from working on developing cancer treatments to coronavirus vaccine. It has been working on the vaccine since late January. Now, it has announced that the first injections of the DNA vaccine candidates have produced neutralising antibodies in test animals. The injections are tested against the Spike protein of the SARS-CoV-2 virus, which causes COVID-19. The next phase of trials is slated to begin this week by the startups’ manufacturing partner, Applied DNA Sciences Inc.

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

“We are proud of the rapid achievements with our Joint Partners in the fight to vanquish COVID-19 through its Spike protein and corresponding gene,” says Dr. James Hayward, CEO of Applied DNA Sciences. “The candidate vaccine constructs lend themselves to rapid manufacturing, and the potential for low-dose vaccination could enhance the power of our platform in a global pandemic, by requiring less manufacturing to vaccinate a given population size. Moreover, the simplicity of our joint approach empowers a technical response to viral mutations within days or weeks. We are especially aware of the irony of collaborating from New York and Rome, two locations so badly struck by COVID-19.”

Vaccine studies happened at the Lazzaro Spallanzani 

Studies for the testing were done at the renowned Lazzaro Spallanzani National Institute for Infectious Diseases in Rome. Spallanzani was among the first to obtain and sequence the novel coronavirus. It also developed unique models for the assessment of vaccines. Dr, Luigi Aurisicchio, CEO and Chief Scientific Officer at Takis, says, “Thanks to the Spallanzani’s skills, as far as we know, we are among the first in the world to have demonstrated the neutralization of the coronavirus by a vaccine. We believe this will also happen in humans.”

Will Takis Biotech win the COVID-19 vaccine race?

As per the World Health Organisation, there are 5 candidate vaccines in clinical evaluation. Four of these trials are in phase 1 and one is already in phase 2.  The one furthest along is by CanSino Biologics and the Beijing Institute of Biotechnology, which is in Phase II. The Boston biopharma company Moderna was in phase 1 and it recently received FDA approval to move into phase 2 of the trials. 

Additionally, there are 71 vaccines for COVID-19 in development worldwide that are currently in the preclinical evaluation phase. Takis Biotech is doing great work, but it is still a bit behind. Takis is now expected to enter pre-clinical and human trials. However, that doesn’t mean that it can’t win the race since it will all come down to testing and evaluating how the vaccine works.

Main image credits: Shutterstock

Stay tuned to Silicon Canals for more European technology news

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Hiring during COVID Intrinsic Search
Hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives
Check out the do's and don'ts while hiring SaaS sales executives Show Less
Read more
Tags: featurednews
Share9Tweet33SendShare63

Partner content | Work with us

Future of coding: CTOs discuss low-code versus custom code software development for their business

Why now is the perfect time to start hiring for 2021

SaaS sales in 2021: 9 predictions from an industry expert

Diversity in hiring for SaaS: the often overlooked topic of ageism

Boost your scale-up’s growth by outsourcing to these top Eastern European software development companies

Subscribe to our daily newsletter

Check your inbox or spam folder to confirm your subscription.

Breaking news from Amsterdam | Partner

4 experts predict what 2021 might hold for the startup ecosystem of Amsterdam

Here’s why Just Eat Takeaway wants to remain listed in Amsterdam

CES 2021: Meet the 12 Amsterdam-based startups in the Dutch delegation

11 AI leaders from Amsterdam to watch in 2021

Advertisement

Trending

Adobe flash
News

Adobe pulls the plug on Flash, but here’s how you can still play some iconic Adobe Flash games

January 4, 2021
3D Hubs
Amsterdam

Amsterdam-based 3D Hubs acquired by Protolabs for €272.1M; here’s what you need to know

January 19, 2021
Amsterdam
Amsterdam

CES 2021: Meet the 12 Amsterdam-based startups in the Dutch delegation

January 13, 2021
  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info